Riskpilot← Back to searchSign inGet full accessPHARMAPOLAR AS
ASActiveOrg 917375232Vinkelveien 2, 3027 DrammenPostordre-/Internetthandel med helsekost · NACE 47917Est. 20160 employees
Revenue 2021
NOK 212K
-18% vs 2020
EBITDA margin
60.1%
+89% vs 2020
Equity ratio
99.3%
Financial strength
Net profit 2021
NOK 111K
+162% vs 2020
| Revenue | NOK 212K | -18% |
| EBITDA | NOK 128K | +89% |
| Net profit | NOK 111K | +162% |
| Total assets | NOK 2,9M | +3% |
| Equity | NOK 2,9M | +4% |
| Employees | 0 | — |
Legal name
PHARMAPOLAR AS
Org number
917375232
Legal form
Aksjeselskap
NACE code
47917 · Postordre-/Internetthandel med helsekost
Founded
28. juni 2016
Share capital
NOK 300 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Handel med helsekost og forlagsvirksomhet, samt det som naturlig står i forbindelse med dette.
Address
Vinkelveien 2, 3027 Drammen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1 343 | 1 185 | 614 | 258 | 212 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −2 915 | −99 | 31 | 67 | 128 |
| Depreciation & amort. | −218 | −218 | −218 | −0 | −0 |
| EBIT | −3 133 | −317 | −187 | 67 | 128 |
| Net financials | −61 | −35 | −26 | −11 | 15 |
| Profit before tax | −3 194 | −352 | −214 | 57 | 143 |
| Tax | −766 | −28 | −24 | 14 | 31 |
| Net profit | −2 428 | −324 | −189 | 42 | 111 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 3 715 | 2 923 | 2 804 | 2 860 | 2 936 |
| Equity | 2 942 | 2 840 | 2 753 | 2 804 | 2 915 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 772 | 83 | 51 | 57 | 21 |
| Total debt | 772 | 83 | 51 | 57 | 21 |
EBITDA margin
60.1%
This company
15.8%
Market median
+280% vs market
20172021
Equity ratio
99.3%
This company
38.2%
Market median
+160% vs market
20172021
Return on equity
3.8%
This company
18.4%
Market median
-79% vs market
20172021
Net profit margin
52.5%
This company
8.1%
Market median
+548% vs market
20172021
Asset turnover
0.07×
This company
1.12×
Market median
-94% vs market
20172021
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20172021
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AR Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
BJ Chief Executive Officer | Chief Executive Officer | 2016 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of PHARMAPOLAR AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bodil Johanne Lien Arnesen | Chief Executive Officer | 0 companies |
| Aleksander Rikard Storvestre | Chief Executive Officer | 0 companies |
| Bernard Jean Y Lemaire | Chairman | 0 companies |
| Eirik Rake Helgesen | Board of Directors | 0 companies |